Jim Simons Magenta Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.62 - $0.79 $54,746 - $69,757	88,300 Added 22.45%	481,700 $365,000
Q1 2023 May 12, 2023	SELL	$0.41 - $0.86 $79,754 - $167,288	-194,522 Reduced 33.09%	393,400 $313,000
Q4 2022 Feb 13, 2023	BUY	$0.36 - $1.59 $65,905 - $291,082	183,071 Added 45.22%	587,922 $232,000
Q3 2022 Nov 14, 2022	SELL	$1.26 - $2.09 $411,383 - $682,374	-326,495 Reduced 44.64%	404,851 $571,000
Q2 2022 Aug 12, 2022	BUY	$0.97 - $3.08 $477,318 - $1.52 Million	492,081 Added 205.66%	731,346 $878,000
Q1 2022 May 13, 2022	BUY	$2.55 - $5.23 $489,564 - $1 Million	191,986 Added 406.07%	239,265 $694,000
Q4 2021 Feb 11, 2022	BUY	$4.43 - $8.33 $101,796 - $191,415	22,979 Added 94.56%	47,279 $209,000
Q3 2021 Nov 12, 2021	BUY	$6.07 - $9.89 $147,501 - $240,327	24,300 New	24,300 $177,000
Q1 2021 May 13, 2021	SELL	$7.66 - $13.38 $1.64 Million - $2.87 Million	-214,200 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$6.1 - $7.94 $905,850 - $1.18 Million	-148,500 Reduced 40.94%	214,200 $1.68 Million
Q3 2020 Nov 13, 2020	BUY	$6.52 - $8.94 $993,647 - $1.36 Million	152,400 Added 72.47%	362,700 $2.47 Million
Q2 2020 Aug 13, 2020	BUY	$6.18 - $10.76 $250,648 - $436,404	40,558 Added 23.89%	210,300 $1.58 Million
Q1 2020 May 14, 2020	BUY	$6.03 - $15.24 $1.02 Million - $2.59 Million	169,742 New	169,742 $1.07 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.